跳至主要内容
临床试验/DRKS00030945
DRKS00030945已完成不适用

Testing the sensitivity and specificity of EUROLINE immunoblots for systemic sclerosis and autoimmune muscle diseases - Sensitivity and specificity testing Immunoblots

niversitätsklinikum Halle Saale, Klinik für Innere Medizin II, Rheumatologie0 个研究点目标入组 1,373 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,373

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Outpatient and inpatient treatment at UKH in the period from 01.01.2018 to 31.12.2021.
  • - Existing test result in the immunoblot EUROLINE for a systemic sclerosis or autoimmune muscle disease.
  • - Confirmed diagnosis by the clinical phenotype of one of the above-mentioned forms of progression, documented in the medical report or in the medical outpatient documentation.

排除标准

  • - Positive blot results without documented diagnosis in the physician's report or in the physician's outpatient documentation

研究者

发起方
niversitätsklinikum Halle Saale, Klinik für Innere Medizin II, Rheumatologie

相似试验